ALNYLAM PHARMACEUTICALS, INC. Operating Income 2008-2025 | ALNY
Beta
What is operating income?
Operating income can be defined as profit from core business operations, calculated as gross profit minus operating expenses, before interest and taxes.
What is ALNYLAM PHARMACEUTICALS, INC.'s current operating income?
ALNYLAM PHARMACEUTICALS, INC. (ALNY) annual operating income for 2025 was $501.6M, a 383.56% increase from 2024. ALNYLAM PHARMACEUTICALS, INC. operating income for the quarter ending December 31, 2025 was $131.7M.
What was ALNYLAM PHARMACEUTICALS, INC.'s operating income in 2024?
ALNYLAM PHARMACEUTICALS, INC. annual operating income for 2024 was $-176.9M, a 37.31% increase from 2023.
What was ALNYLAM PHARMACEUTICALS, INC.'s operating income in 2023?
ALNYLAM PHARMACEUTICALS, INC. annual operating income for 2023 was $-282.2M, a 64.06% increase from 2022.
Operating Income History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGRN/A
FY2020
$-828.4M
→
FY2025
$501.6M
080910111213141516171819202122232425
5 years selected
Operating Income History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $501.6M | +383.6% | 10-K |
| FY2024 | $-176.9M | +37.3% | 10-K |
| FY2023 | $-282.2M | +64.1% | 10-K |
| FY2022 | $-785.1M | -10.8% | 10-K |
| FY2021 | $-708.7M | +14.5% | 10-K |
| FY2020 | $-828.4M | +11.8% | 10-K |
| FY2019 | $-939.4M | -15.3% | 10-K |
| FY2018 | $-814.7M | -62.9% | 10-K |
| FY2017 | $-500.1M | -17.8% | 10-K |
| FY2016 | $-424.6M | -43.4% | 10-K |
| FY2015 | $-296.0M | +26.9% | 10-K |
| FY2014 | $-405.0M | -335.7% | 10-K |
| FY2013 | $-92.9M | +28.2% | 10-K |
| FY2012 | $-129.5M | -136.2% | 10-K |
| FY2011 | $-54.8M | -24.4% | 10-K |
| FY2010 | $-44.1M | +8.4% | 10-K |
| FY2009 | $-48.1M | -72.8% | 10-K |
| FY2008 | $-27.8M | - | 10-K |
Company: ALNYLAM PHARMACEUTICALS, INC.Ticker: ALNYSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →